CNTB
CNTB
NASDAQ · Biotechnology

Connect Biopharma Holdings L

$1.08
+0.00 (+0.00%)
As of Sep 28, 10:20 PM ET ·
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 13 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +1,803.7% upside
Low Target $15.18
Average Target $20.56
High Target $23.56
Current Price $1.08
Current
$1.08
Target
$20.56
$15.18 $20.56 avg $23.56
Scenario Analysis
Bear Case
$15.18
1,305.6%
Low target
Base Case
$20.56
+1,803.7%
Avg target
Bull Case
$23.56
+2,081.5%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$3.82
-71.7% from high
52-Week Low
$1.06
+1.8% from low
Target vs 52W High
$20.56
+438.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.2%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.9%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +139.7%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.8%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -26.5%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.5%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.2%